rs35853292

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_002234.4(KCNA5):ā€‹c.633G>Cā€‹(p.Glu211Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00174 in 1,614,208 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.0012 ( 0 hom., cov: 33)
Exomes š‘“: 0.0018 ( 4 hom. )

Consequence

KCNA5
NM_002234.4 missense

Scores

4
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:5

Conservation

PhyloP100: 1.73
Variant links:
Genes affected
KCNA5 (HGNC:6224): (potassium voltage-gated channel subfamily A member 5) Potassium channels represent the most complex class of voltage-gated ino channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. Four sequence-related potassium channel genes - shaker, shaw, shab, and shal - have been identified in Drosophila, and each has been shown to have human homolog(s). This gene encodes a member of the potassium channel, voltage-gated, shaker-related subfamily. This member contains six membrane-spanning domains with a shaker-type repeat in the fourth segment. It belongs to the delayed rectifier class, the function of which could restore the resting membrane potential of beta cells after depolarization and thereby contribute to the regulation of insulin secretion. This gene is intronless, and the gene is clustered with genes KCNA1 and KCNA6 on chromosome 12. Defects in this gene are a cause of familial atrial fibrillation type 7 (ATFB7). [provided by RefSeq, May 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.026509643).
BP6
Variant 12-5044780-G-C is Benign according to our data. Variant chr12-5044780-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 191459.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=2, Likely_benign=3}. Variant chr12-5044780-G-C is described in Lovd as [Likely_benign].
BS2
High AC in GnomAd4 at 186 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
KCNA5NM_002234.4 linkuse as main transcriptc.633G>C p.Glu211Asp missense_variant 1/1 ENST00000252321.5 NP_002225.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
KCNA5ENST00000252321.5 linkuse as main transcriptc.633G>C p.Glu211Asp missense_variant 1/1 NM_002234.4 ENSP00000252321 P1P22460-1

Frequencies

GnomAD3 genomes
AF:
0.00122
AC:
186
AN:
152216
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000627
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00105
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00200
Gnomad OTH
AF:
0.00287
GnomAD3 exomes
AF:
0.000879
AC:
221
AN:
251394
Hom.:
0
AF XY:
0.000927
AC XY:
126
AN XY:
135908
show subpopulations
Gnomad AFR exome
AF:
0.000431
Gnomad AMR exome
AF:
0.000463
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000925
Gnomad NFE exome
AF:
0.00166
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.00179
AC:
2619
AN:
1461874
Hom.:
4
Cov.:
32
AF XY:
0.00177
AC XY:
1284
AN XY:
727236
show subpopulations
Gnomad4 AFR exome
AF:
0.000388
Gnomad4 AMR exome
AF:
0.000626
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.000206
Gnomad4 NFE exome
AF:
0.00224
Gnomad4 OTH exome
AF:
0.00123
GnomAD4 genome
AF:
0.00122
AC:
186
AN:
152334
Hom.:
0
Cov.:
33
AF XY:
0.00125
AC XY:
93
AN XY:
74488
show subpopulations
Gnomad4 AFR
AF:
0.000625
Gnomad4 AMR
AF:
0.00104
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000188
Gnomad4 NFE
AF:
0.00200
Gnomad4 OTH
AF:
0.00284
Alfa
AF:
0.00133
Hom.:
0
Bravo
AF:
0.00126
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00285
AC:
11
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00151
AC:
13
ExAC
AF:
0.000832
AC:
101
EpiCase
AF:
0.00164
EpiControl
AF:
0.00202

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Atrial fibrillation, familial, 7 Uncertain:1Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 22, 2024- -
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
not provided Benign:2
Likely benign, criteria provided, single submitterclinical testingGeneDxJun 04, 2024See Variant Classification Assertion Criteria. -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenOct 01, 2024KCNA5: BP4, BS1, BS2 -
Pulmonary hypertension, primary, 1 Uncertain:1
Uncertain significance, criteria provided, single submitterresearchBiesecker Lab/Clinical Genomics Section, National Institutes of HealthJun 24, 2013- -
not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMar 31, 2024- -
KCNA5-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesFeb 26, 2022This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
19
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.48
T
Eigen
Benign
-0.27
Eigen_PC
Benign
-0.13
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.85
D
M_CAP
Benign
0.020
T
MetaRNN
Benign
0.027
T
MetaSVM
Benign
-0.63
T
MutationAssessor
Benign
1.2
L
MutationTaster
Benign
0.80
D
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
-1.2
N
REVEL
Benign
0.19
Sift
Benign
0.16
T
Sift4G
Benign
0.26
T
Polyphen
0.0060
B
Vest4
0.055
MutPred
0.40
Loss of helix (P = 0.0626);
MVP
0.97
MPC
0.48
ClinPred
0.0087
T
GERP RS
2.8
Varity_R
0.15
gMVP
0.74

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs35853292; hg19: chr12-5153946; API